share_log

Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Decreases By 87.5%

kopsource ·  Mar 10, 2023 21:40

Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 200 shares, a decrease of 87.5% from the February 13th total of 1,600 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 0.1 days.

Mayne Pharma Group Stock Performance

Shares of MAYNF remained flat at $2.49 during mid-day trading on Friday. 500 shares of the company were exchanged, compared to its average volume of 1,360. Mayne Pharma Group has a 12-month low of $2.00 and a 12-month high of $5.87. The company has a 50-day moving average of $2.32 and a two-hundred day moving average of $3.15.

Get Mayne Pharma Group alerts:

About Mayne Pharma Group

(Get Rating)

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products.

Featured Stories

  • Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
  • 2 Offshore Drilling Stocks Set to Extract Big Profits
  • Three Staples Stocks With Double-Digit Upside Ahead
  • Can Investors Trust Consumers to Lift American Outdoor Brands?
  • How to Buy High Yielding Dividend Stocks
  • Oracle Has Spoken: Shares Fall 5%

Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment